Traumatic Brain Injury (TBI) is an injury caused by external force to the head resulting in damage to the brain. This type of injury can cause physical, emotional, cognitive, and behavioural changes to the person's life. Common causes of a TBI include motor vehicle accidents, falls, assault, sports and recreational activities, and physical violence. TBI can be classified into mild, moderate, and severe depending on the severity of the condition. Mild TBI or concussion involves temporary loss of consciousness and associated physical symptoms such as headache, nausea, dizziness, confusion, and memory problems. Moderate TBI involves occupational and cognitive difficulties, sensory problems, difficulty communicating, and limited physical capabilities. Severe TBI occurs when a person experiences significant physical damage to the brain resulting in long-term changes in cognitive, physical, and psychosocial functioning. The short- and long-term impacts of a TBI will vary depending on the severity of the condition. Short-term impacts can range from physical and cognitive impairments to significant emotional, behavioural, and social challenges. Long term impacts may include physical disability, persistent cognitive difficulties, emotional and behavioural problems, and a lowered baseline performance level. In order to address the different aspects of TBI, it is important to have a multi-disciplinary approach to treating and managing the condition. Medical professionals such as neurologists, physical and occupational therapists, psychiatrists, and neuropsychologists should work together to develop a comprehensive treatment approach. Therapy can help to address physical, cognitive, emotional, and behavioural needs, while medications can help to alleviate some of the symptoms. Education and support for people with TBI, their families, and their carers, is important in order to ensure appropriate understanding of the condition and to provide the best care possible.
Title : Personalized and Precision Medicine (PPM), as a unique healthcare model through biodesign-driven biotech and biopharma, translational applications, and neurology-related biomarketing to secure human healthcare and biosafety
Sergey Victorovich Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Narrative medicine: A communication therapy for the communication disorder of Functional Seizures (FS) [also known as Psychogenic Non-Epileptic Seizures (PNES)]
Robert B Slocum, University of Kentucky HealthCare, United States
Title : Neuro sensorium
Luiz Moutinho, University of Suffolk, United Kingdom
Title : GBF1 inhibition reduces amyloid-beta levels in viable human postmortem Alzheimer's disease cortical explant and cortical organoid models
Sean J Miller, Yale School of Medicine, United States
Title : Study of resilience in cases of incest, father-daughter, step-father and step-daughter in the pre-pubber and puberous period among adult women and mothers: How to overcome the traumatisms of an incestuous relationship?
Daniele Lapointe, Laval University, Canada
Title : Traumatic Spinal Cord Injuries (tSCI) - Are the radiologically based “advances” in the management of the injured spine evidence-based?
W S El Masri, Keele University, United Kingdom